Paper25985403
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.
Martin M and 15 others. AIDS, 2015. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. Papers, record 25985403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25985403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| Medication Adherence | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Substance Abuse, Intravenous | Major topic |
| Adult | |
| Anti-HIV Agents | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Medical Records | |
| Middle Aged | |
| Risk Assessment | |
| Tenofovir | |
| Young Adult |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00119106 | Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand | Background | Yes | ClinicalTrials.gov |
| NCT04523519 | PrEP Intervention for People Who Inject Substances and Use Methamphetamine | Background | ClinicalTrials.gov |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42778687 | Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/42778687 | PubMed |
| 41678009 | Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities. | AIDS Behav | 2026 | https://conductscience.org/library/papers/41678009 | PubMed |
| 41419251 | Oral PrEP continuation rates among key populations in Nigeria: a retrospective cohort study of a large-scale HIV prevention programme. | BMJ Glob Health | 2025 | https://conductscience.org/library/papers/41419251 | PubMed |
| 41312653 | Informal PrEP use in Greece: The long, hard road to formal programmatic implementation. | HIV Med | 2026 | https://conductscience.org/library/papers/41312653 | PubMed |
| 41082154 | Digital Interventions for Stimulant Use Among People Living with HIV: A Narrative Review. | Curr HIV/AIDS Rep | 2025 | https://conductscience.org/library/papers/41082154 | PubMed |
| 40672761 | Willingness to Take Long-Acting Injectable Preexposure Prophylaxis (PrEP) and Preference for PrEP Modalities Among People Who Inject Drugs in Washington, DC. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/40672761 | PubMed |
| 40406373 | Interest in Long-Acting Preexposure Prophylaxis (PrEP) Among Men at Risk for Human Immunodeficiency Virus Who Use Methamphetamine Participating in a Daily, Oral PrEP Adherence Trial in San Francisco, California. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/40406373 | PubMed |
| 40244556 | Disparities in United States Nationwide County-Level PrEP Rate and PrEP to Need Ratio During the COVID-19 Pandemic. | J Racial Ethn Health Disparities | 2026 | https://conductscience.org/library/papers/40244556 | PubMed |
| 40222706 | Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention. | J Subst Use Addict Treat | 2025 | https://conductscience.org/library/papers/40222706 | PubMed |
| 40057242 | Implementing a pre-exposure prophylaxis (PrEP) promotion intervention among persons who inject drugs: Perspectives from community and research implementation partners. | J Subst Use Addict Treat | 2025 | https://conductscience.org/library/papers/40057242 | PubMed |
| 39781235 | The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021. | Can Commun Dis Rep | 2025 | https://conductscience.org/library/papers/39781235 | PubMed |
| 39104432 | Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists. | Ment Health Clin | 2024 | https://conductscience.org/library/papers/39104432 | PubMed |
| 39030884 | Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers. | J Int AIDS Soc | 2024 | https://conductscience.org/library/papers/39030884 | PubMed |
| 38722201 | User Experience of Persons Using Ingestible Sensor-Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study. | JMIR Mhealth Uhealth | 2024 | https://conductscience.org/library/papers/38722201 | PubMed |
| 38290644 | "PrEPping" women's healthcare providers: motivational interviewing to support ending the HIV epidemic. | Am J Obstet Gynecol | 2024 | https://conductscience.org/library/papers/38290644 | PubMed |
| 38032345 | A Decade of HIV Preexposure Prophylaxis (PrEP): Overcoming Access Barriers in the United States Through Expanded Delivery. | Public Health Rep | 2024 | https://conductscience.org/library/papers/38032345 | PubMed |
| 37898146 | Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. | Lancet HIV | 2023 | https://conductscience.org/library/papers/37898146 | PubMed |
| 37732092 | The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations. | Front Public Health | 2023 | https://conductscience.org/library/papers/37732092 | PubMed |
| 37335757 | Sexually transmitted infections in Spain: Current status. | Rev Esp Quimioter | 2023 | https://conductscience.org/library/papers/37335757 | PubMed |
| 36962766 | Awareness and willingness to use HIV oral pre-exposure prophylaxis among people who inject drugs in Dar es Salaam, Tanzania: A cross-sectional survey. | PLOS Glob Public Health | 2022 | https://conductscience.org/library/papers/36962766 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25985403
GET https://conductscience.org/api/papers/v1/25985403/cited_by?page=2